Risk Factors for Node Affectation and Recurrence in Endometrial Cancer

被引:0
作者
Alonso, Sonsoles [1 ]
Lapuente, Fernando [1 ]
Gonzalez-Martin, Antonio [1 ]
Chiva, Luis [1 ]
机构
[1] MD Anderson Int Espana, Dept Gynecol Oncol, Madrid, Spain
关键词
Endometrial cancer; lymphadenectomy; pelvic nodes; para-aortic nodes; prognostic factors;
D O I
10.2174/157340411799079526
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometrial cancer is the most common gynecologic malignancy in western countries. In United States, 42000 estimated new cases were diagnosed in 2009, approximately 7780 women died from this cancer last year. This malignancy has a five year survival rate around 80%, thanks to its early diagnosis. The surgical management of endometrial cancer includes hysterectomy as main surgical procedure. The role of lymphadenectomy, pelvic and para aortic is still controversial. The authors discuss in this article the risk factors for lymph node metastases and recurrence for endometrial cancer by reviewing the international literature. Conclusions: Lymphadenectomy is a crucial surgical procedure for an adequate staging of endometrial cancer. It is necessary a to evaluate the prognostic factors of this disease in order to properly select the most adequate adjuvant therapy. Since last trials on lymphadenectomy in endometrial cancer have not been convincing, further studies are warranted.
引用
收藏
页码:320 / 325
页数:6
相关论文
共 26 条
[1]   Endometrial cancer [J].
Amant, F ;
Moerman, P ;
Neven, P ;
Timmerman, D ;
Van Limbergen, E ;
Vergote, I .
LANCET, 2005, 366 (9484) :491-505
[2]  
[Anonymous], 1989, GYNECOL ONCOL, V35, P125, DOI DOI 10.1016/0090-8258(89)90027-9
[3]   Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: Results of a pilot study [J].
Burke, TW ;
Levenback, C ;
Tornos, C ;
Morris, M ;
Wharton, JT ;
Gershenson, DM .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :169-173
[4]   The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology [J].
Chi, D. S. ;
Barakat, R. R. ;
Palayekar, M. J. ;
Levine, D. A. ;
Sonoda, Y. ;
Alektiar, K. ;
Brown, C. L. ;
Abu-Rustum, N. R. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) :269-273
[5]   Physical activity, adiposity, and risk of endometrial cancer [J].
Conroy, Molly B. ;
Sattelmair, Jacob R. ;
Cook, Nancy R. ;
Manson, JoAnn E. ;
Buring, Julie E. ;
Lee, I-Min .
CANCER CAUSES & CONTROL, 2009, 20 (07) :1107-1115
[6]   ASTEC lymphadenectomy and radiation therapy studies: Are conclusions valid? [J].
Creasman, W. T. ;
Mutch, David E. ;
Herzog, Thomas J. .
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :293-294
[7]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[8]  
2-8
[9]   Biologic markers in endometrial cancer treatment [J].
Engelsen, Ingeborg B. ;
Akslen, Lars A. ;
Salvesen, Helga B. .
APMIS, 2009, 117 (10) :693-707
[10]   p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes [J].
Garg, Karuna ;
Leitao, Mario M., Jr. ;
Wynveen, Christine A. ;
Sica, Gabriel L. ;
Shia, Jinru ;
Shi, Weiji ;
Soslow, Robert A. .
MODERN PATHOLOGY, 2010, 23 (01) :80-92